<DOC>
	<DOCNO>NCT02604225</DOCNO>
	<brief_summary>A phase 3 double-blind placebo-controlled randomize trial methoxyflurane periprostatic local anaesthesia reduce discomfort transrectal ultrasound-guided prostate biopsy ( Pain-Free TRUS B ) .</brief_summary>
	<brief_title>Trial Methoxyflurane With Periprostatic Local Anaesthesia Reduce Discomfort TRUS B</brief_title>
	<detailed_description>Background Transrectal ultrasound-guided ( TRUS ) prostate biopsy associate significant discomfort , despite use periprostatic infiltration local anaesthetic ( PILA ) . General aim To determine efficacy safety inhale methoxyflurane plus PILA versus PILA alone men undergo TRUS biopsy prostate . Objectives ( endpoint ) To determine effect inhale methoxyflurane : Primary 1 . Pain-rated participant 15 minute biopsy . Secondary 2 . Other aspect biopsy experience rat participant 15 minute 7-35 day biopsy 3 . Willingness undergo biopsy future 4 . Urologist 's rating participant 's biopsy experience ( study specific questionnaire complete biopsy ) 5 . Biopsy completion ( 80 % plan number biopsy take ) 6 . Frequency specify adverse event ( CTC AE v4.03 Clavien-Dindo Classification ) . 7 . Frequency hospitalisation Design Multi-centre , placebo-controlled , double-blinded , centrally randomise ( 1:1 ) , stratify , phase 3 trial . Target population Men schedule undergo first TRUS biopsy prostate raise PSA abnormal digital rectal examination ( DRE ) . Study treatments Participants randomise inhale : Methoxyflurane ( Penthrox® , experimental group ) . OR Placebo ( 0.9 % saline , control group All participants subsequently treat PILA ( 2 % lignocaine ) , inject around prostate 5 minute biopsy . Assessments Participants assess time schedule TRUS prostate biopsy ( 84 day prior randomisation ) , day biopsy , post biopsy clinic ( 7-35 day biopsy ) . Assessments comprise medical history standard blood test baseline , patient questionnaire day biopsy post ( 7-35 day ) biopsy safety assessment day biopsy post ( 7 -- 35 day ) biopsy . Statistical consideration 420 participant provide 85 % power two-sided 5 % level significance detect 0.80 point difference mean pain score ( scale 0-10 ) assume standard deviation 2.5 whilst allow miss data . A 0.80 point shift mean pain score correspond reduction 1/3 proportion men report troublesome level pain .</detailed_description>
	<mesh_term>Methoxyflurane</mesh_term>
	<criteria>1 . Males old 18 year schedule undergo TRUS biopsy prostate . 2 . Adequate liver function : ALT , AST , bilirubin ≤ 2 x ULN 3 . Adequate renal function : serum eGFR &gt; 30 ml/min/1.73m2 4 . Willing able complete questionnaire English 5 . Willing able undergo TRUS biopsy within 7 day randomisation 6 . Willing able comply study requirement , include treatment , time and/or nature require assessment 7 . Signed , write informed consent 1 . Previous TRUS biopsy prostate 2 . Personal family history malignant hyperthermia 3 . History significant liver disease 4 . Hypersensitivity fluorinated anaesthetic inhalational anaesthetic 5 . Concurrent use barbiturates tetracycline antibiotic 6 . Concurrent illness may jeopardise ability patient undergo procedure outline protocol reasonable safety 7 . Presence psychological , familial , sociological geographical condition potentially hamper compliance study protocol followup schedule , include alcohol dependence drug abuse .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Anaethesiology</keyword>
</DOC>